Related references
Note: Only part of the references are listed.Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors
Wanlu Cao et al.
CARCINOGENESIS (2019)
Mutational landscape of a chemically-induced mouse model of liver cancer
Frances Connor et al.
JOURNAL OF HEPATOLOGY (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
Zachary J. Brown et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cancer cell plasticity: Impact on tumor progression and therapy response
Victoria da Silva-Diz et al.
SEMINARS IN CANCER BIOLOGY (2018)
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Sandro Nuciforo et al.
CELL REPORTS (2018)
A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
Adriana Sanchez-Danes et al.
NATURE (2018)
Integrative genomic analysis of mouse and human hepatocellular carcinoma
Michelle Dow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual et al.
NATURE (2017)
Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury
Wanlu Cao et al.
GASTROENTEROLOGY (2017)
A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
Felipe de Sousa e Melo et al.
NATURE (2017)
Visualization and targeting of LGR5+ human colon cancer stem cells
Mariko Shimokawa et al.
NATURE (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
Ruth Nussinov et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog
Armel Herve Nwabo Kamdje et al.
CANCER BIOLOGY & MEDICINE (2017)
Intestinal cancer stem cells marked by Bmi1 or Lgr5 expression contribute to tumor propagation via clonal expansion
Hirotsugu Yanai et al.
SCIENTIFIC REPORTS (2017)
R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis
Xiaolin Zhou et al.
CANCER RESEARCH (2017)
Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer
Hideki Osawa et al.
BRITISH JOURNAL OF CANCER (2016)
Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters
Paul W. Tetteh et al.
CELL STEM CELL (2016)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice
R. Tolba et al.
LABORATORY ANIMALS (2015)
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer
Melissa R. Junttila et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Mapping early fate determination in Lgr5+ crypt stem cells using a novel Ki67-RFP allele
Onur Basak et al.
EMBO JOURNAL (2014)
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Soufiane Boumahdi et al.
NATURE (2014)
Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer
Hong-Qing Xi et al.
ONCOLOGY REPORTS (2014)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Intestinal label-retaining cells are secretory precursors expressing Lgr5
Simon J. A. Buczacki et al.
NATURE (2013)
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Meritxell Huch et al.
NATURE (2013)
Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
Bon-Kyoung Koo et al.
NATURE (2012)
Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
Arnout G. Schepers et al.
SCIENCE (2012)
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable
Hua Tian et al.
NATURE (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling
W. van Veelen et al.
ONCOGENE (2011)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
The cancer stem cell paradigm: a new understanding of tumor development and treatment
Johnathan D. Ebben et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin
Andrea Haegebarth et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Crypt stem cells as the cells-of-origin of intestinal cancer
Nick Barker et al.
NATURE (2009)
Identification of stem cells in small intestine and colon by marker gene Lgr5
Nick Barker et al.
NATURE (2007)
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
Elisa Wurmbach et al.
HEPATOLOGY (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Overexpression of orphan G-Protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with β-catenin mutations
Y Yamamoto et al.
HEPATOLOGY (2003)